[Cooper:] Two new reports say a major boost in testing is in need of handling the pandemic. One calls for a three to 30 tests a day are needed. The other says 20 million tests a day are needed. New York's governor says that'll be the biggest topic of conversation when he meets with President Trump at the White House today. Meantime, the FDA just approved the first at-home coronavirus test for emergency use. CNN Senior Medical Correspondent, Elizabeth Cohen, is with us. Some study results or lack of effectiveness or lack of effectiveness of Hydroxychloroquine.
[Dr. Elizabeth Cohen, Cnn Senior Medical Correspondent:] That's right, Hydroxychloroquine you may remember is the drug that President Trump has been touting, calling it a game changer. This study, done by Veterans Administration doctors, found that those who took Hydroxychloroquine, the drug that Trump likes. had more than twice the death rate compares to patients who did not take it. One note of caution, this study was published on the preprint Web site. It has not been reviewed by other physicians and not been published. Hydroxychloroquine is one of this drugs that are being studied. Also. at the same time, doctors are really trying to get antibody testing going. That's testing that can see, it is not about treatment but testing to see how may already possibly have antibodies to coronavirus and may be immune.
[Cohen:] Antibody testings, we can't get back to normal without it.
[Deborah Birx, Coordinator, White House Coronavirus Task Force:] The antibody piece is critical.
[Cohen:] These tests shows whether you have been infected with COVID-19 and develop antibodies and may be immune. This week, we are learning there are several problems. One, some of the tests don't work.
[Dr. Anthony Fauci, Director, National Institute Of Allergy & Infectious Diseases:] The problem is that these tests need to be validated and calibrated. Many of the tests out there don't do that.
[Cohen:] Two, the tests need certain materials to make it work. Many officials say it is not enough of these supplies.
[Anthony Cuomo, , New York Governor:] Those labs can only run as many tests as the national manufactures provide them chemicals, reagents and lab kits. The national manufactures say there are supply chain issues. I would like the federal government to help on those supply chain issues.
[Cohen:] Even if you have antibodies, it is not clear what it means.
[Fauci:] There's an assumption, a reasonable assumption that when you have an antibody that you're protect against reinfection. But that has not been proven for this particular virus.
[Cohen:] While work on antibody testing continue, researchers are working on a drug that'll fight COVID-19. Novartis announces it will begin new clinical trials to study Hydroxychloroquine. President Trump has touted this drug. And there are 25 other studies that are getting started. The University of California, San Francisco, is recruiting 6,000 patients with COVID to see if the anti-inflammatory will treat it. It is used now to treat gouts. Hoping one drug or another will save people from dying during this pandemic. Looking again at Hydroxychloroquine, that's the drug that Trump has been touting, it is a mystery here. Anderson, we were told yesterday to expect results from a New York study of preliminary results of a large study we are looking to see what that would find. It was not released and not exactly clear why Governor Cuomo talked about having to share some information with federal agencies. We don't know when we are going to be getting those result Anderson?
[Cooper:] Thank you, Elizabeth Cohen. Appreciate it. President Trump comes to the rescue of oil and gas companies today after an historic drop in oil prices and as the pandemic continues to torpedo demands. Plus, U.S. official monitoring that Kim Jong-Un may be in a grave condition after a surgery. We'll tell you what we know about the North Korean leader's health, coming up.